Australia markets open in 9 hours 47 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
59.61-0.88 (-1.45%)
At close: 04:00PM EST
59.61 0.00 (0.00%)
After hours: 04:14PM EST

Integra LifeSciences Holdings Corporation

1100 Campus Road
Princeton, NJ 08540
United States
609 275 0500

IndustryMedical Devices
Full-time employees3,800

Key executives

NameTitlePayExercisedYear born
Mr. Jan De WittePres, CEO & Director899.08kN/A1964
Mr. Robert T. Davis Jr.Exec. VP & Pres of Tissue Technologies975.6kN/A1959
Mr. Michael J. McBreenExec. VP & Pres of Codman Specialty Surgical855.88kN/A1966
Mr. Stephen LeonardCorp. VP of Global Operations & Supply ChainN/AN/A1962
Mr. Jeffrey MosebrookSr. VP, SVP of Fin., Principal Financial Officer, Principal Accounting Officer & Corp. ControllerN/AN/A1976
Mr. Mathieu AussermeierVP of Corp. Fin., Investor Relations & TreasurerN/AN/AN/A
Dr. Kenneth E. Burhop Ph.D.Corp. VP & Chief Scientific OfficerN/AN/A1954
Mr. William ComptonChief Information Officer & Corp. VPN/AN/AN/A
Mr. Eric Ian SchwartzExec. VP, Chief Legal Officer & Sec.N/AN/A1969
Laurene IsipVP of Global Corp. Communications & PRN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Corporate governance

Integra LifeSciences Holdings Corporation’s ISS governance QualityScore as of 1 February 2023 is 1. The pillar scores are Audit: 1; Board: 4; Shareholder rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.